Table 1.
The relative abundance profile of different genomes in control and patient groups for the simulated dataset.
| Genomes | NCBI Accession ID | Relative_Abundance_H∗ | Relative_Abundance_P∗ | ||
|---|---|---|---|---|---|
| Bacteroides thetaiotaomicron 7330 | NZ_CP012937.1 | 18% | |||
| Bacteroides thetaiotaomicron VPI-5482 | NC_004663.1 | 0 | 6% | ||
| Bacteroides uniformis CL03T12C37 | NZ_JH724268.1 | 7% | |||
| Alistipes putredinis isolate CAG | MNQH01000001.1 | 16% | |||
| Parabacteroides merdae 2789STDY5834848 | CZAG01000002.1 | 10% | |||
| Dorea longicatena 2789STDY5834914 | NZ_CZAY01000001.1 | 10% | |||
| Ruminococcus bromii L2-63 | FP929051.1 | 10% | |||
| Bacteroides caccae ATCC 43185 | NZ_CP022412.2 | 9% | 3% | ||
| Clostridium sp. SS2/1 | NZ_DS547029.1 | 8% | |||
| Eubacterium hallii isolate EH1 | NZ_LT907978.1 | 6% | |||
| Ruminococcus torques L2-14 | FP929055.1 | 6% | |||
The relative abundances were the proportions of the number of copies of 11 genomes within the community. Bacteroides thetaiotaomicron VPI-5482 is present only in the patient group, and it is another strain of B. thetaiotaomicron. Bacteroides caccae ATCC 43185 has threefold abundance in the control group of that in the patient group. ∗H, healthy control; P, patient.